{"transactions":[{"id":1015827,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-21T00:00:02.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":45513,"price":1.76,"value":80102.88,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1518893,"source":{"system":"sec-edgar","filing":"0001231919-25-000335","document":"form4-10202025_111053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000335/form4-10202025_111053.xml","form_type":"4"}},{"id":1015826,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-21T00:00:02.000Z","date":"2025-10-16","kind":"sale","planned":false,"acquired":false,"shares":85798,"price":1.72,"value":147572.56,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.795 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1564406,"source":{"system":"sec-edgar","filing":"0001231919-25-000335","document":"form4-10202025_111053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000335/form4-10202025_111053.xml","form_type":"4"}},{"id":1018412,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-16T00:07:14.000Z","date":"2025-10-15","kind":"sale","planned":false,"acquired":false,"shares":17960,"price":1.65,"value":29634.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.60 to $1.685 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1650204,"source":{"system":"sec-edgar","filing":"0001231919-25-000323","document":"form4-10162025_121006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000323/form4-10162025_121006.xml","form_type":"4"}},{"id":1018411,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-16T00:07:14.000Z","date":"2025-10-14","kind":"sale","planned":false,"acquired":false,"shares":28495,"price":1.65,"value":47016.75,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1668164,"source":{"system":"sec-edgar","filing":"0001231919-25-000323","document":"form4-10162025_121006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000323/form4-10162025_121006.xml","form_type":"4"}},{"id":1018410,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-16T00:07:14.000Z","date":"2025-10-13","kind":"sale","planned":false,"acquired":false,"shares":107361,"price":1.7,"value":182513.7,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1696659,"source":{"system":"sec-edgar","filing":"0001231919-25-000323","document":"form4-10162025_121006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000323/form4-10162025_121006.xml","form_type":"4"}},{"id":1020226,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-10T21:58:02.000Z","date":"2025-10-10","kind":"sale","planned":false,"acquired":false,"shares":2390,"price":1.77,"value":4230.3,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1804020,"source":{"system":"sec-edgar","filing":"0001231919-25-000308","document":"form4-10102025_091053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000308/form4-10102025_091053.xml","form_type":"4"}},{"id":1020225,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-10T21:58:02.000Z","date":"2025-10-09","kind":"sale","planned":false,"acquired":false,"shares":3979,"price":1.81,"value":7201.99,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1806410,"source":{"system":"sec-edgar","filing":"0001231919-25-000308","document":"form4-10102025_091053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000308/form4-10102025_091053.xml","form_type":"4"}},{"id":1020224,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-10T21:58:02.000Z","date":"2025-10-08","kind":"sale","planned":false,"acquired":false,"shares":7507,"price":1.77,"value":13287.39,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.805 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1810389,"source":{"system":"sec-edgar","filing":"0001231919-25-000308","document":"form4-10102025_091053.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000308/form4-10102025_091053.xml","form_type":"4"}},{"id":1022148,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-07T22:14:58.000Z","date":"2025-10-07","kind":"sale","planned":false,"acquired":false,"shares":2100,"price":1.79,"value":3759.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1817896,"source":{"system":"sec-edgar","filing":"0001231919-25-000292","document":"form4-10072025_101049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000292/form4-10072025_101049.xml","form_type":"4"}},{"id":1022147,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-07T22:14:58.000Z","date":"2025-10-06","kind":"sale","planned":false,"acquired":false,"shares":17500,"price":1.78,"value":31150.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.7879 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1819996,"source":{"system":"sec-edgar","filing":"0001231919-25-000292","document":"form4-10072025_101049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000292/form4-10072025_101049.xml","form_type":"4"}},{"id":1022146,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-07T22:14:58.000Z","date":"2025-10-03","kind":"sale","planned":false,"acquired":false,"shares":600,"price":1.76,"value":1056.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.73 to $1.79 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1837496,"source":{"system":"sec-edgar","filing":"0001231919-25-000292","document":"form4-10072025_101049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000292/form4-10072025_101049.xml","form_type":"4"}},{"id":1027131,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-03T00:51:46.000Z","date":"2025-10-02","kind":"sale","planned":false,"acquired":false,"shares":600,"price":1.73,"value":1038.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.74 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1838096,"source":{"system":"sec-edgar","filing":"0001231919-25-000278","document":"form4-10032025_121037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000278/form4-10032025_121037.xml","form_type":"4"}},{"id":1027130,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-03T00:51:46.000Z","date":"2025-10-01","kind":"sale","planned":false,"acquired":false,"shares":2601,"price":1.8,"value":4681.8,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.785 to $1.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1838696,"source":{"system":"sec-edgar","filing":"0001231919-25-000278","document":"form4-10032025_121037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000278/form4-10032025_121037.xml","form_type":"4"}},{"id":1027129,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74132,"kind":"organization","name":"Decheng Capital Management II (Cayman), LLC","position":4,"cik":"0002089149","reported_name":"Decheng Capital Management II (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":5,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":6,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":7,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-03T00:51:46.000Z","date":"2025-09-30","kind":"sale","planned":false,"acquired":false,"shares":4464,"price":1.81,"value":8079.84,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.83 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1841297,"source":{"system":"sec-edgar","filing":"0001231919-25-000278","document":"form4-10032025_121037.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000278/form4-10032025_121037.xml","form_type":"4"}},{"id":1031165,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-30T00:06:37.000Z","date":"2025-09-29","kind":"sale","planned":false,"acquired":false,"shares":500,"price":1.75,"value":875.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1845761,"source":{"system":"sec-edgar","filing":"0001231919-25-000258","document":"form4-09302025_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000258/form4-09302025_120929.xml","form_type":"4"}},{"id":1031164,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-30T00:06:37.000Z","date":"2025-09-26","kind":"sale","planned":false,"acquired":false,"shares":600,"price":1.68,"value":1008.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.73 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1846261,"source":{"system":"sec-edgar","filing":"0001231919-25-000258","document":"form4-09302025_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000258/form4-09302025_120929.xml","form_type":"4"}},{"id":1031163,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-30T00:06:37.000Z","date":"2025-09-25","kind":"sale","planned":false,"acquired":false,"shares":700,"price":1.66,"value":1162.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.64 to $1.67 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1846861,"source":{"system":"sec-edgar","filing":"0001231919-25-000258","document":"form4-09302025_120929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000258/form4-09302025_120929.xml","form_type":"4"}},{"id":1033011,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-24T22:49:10.000Z","date":"2025-09-24","kind":"sale","planned":false,"acquired":false,"shares":2256,"price":1.68,"value":3790.08,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.67 to $1.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1847561,"source":{"system":"sec-edgar","filing":"0001231919-25-000244","document":"form4-09242025_100902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000244/form4-09242025_100902.xml","form_type":"4"}},{"id":1033010,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-24T22:49:10.000Z","date":"2025-09-23","kind":"sale","planned":false,"acquired":false,"shares":4106,"price":1.72,"value":7062.32,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1849817,"source":{"system":"sec-edgar","filing":"0001231919-25-000244","document":"form4-09242025_100902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000244/form4-09242025_100902.xml","form_type":"4"}},{"id":1033009,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-24T22:49:10.000Z","date":"2025-09-22","kind":"sale","planned":false,"acquired":false,"shares":5410,"price":1.83,"value":9900.3,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1853923,"source":{"system":"sec-edgar","filing":"0001231919-25-000244","document":"form4-09242025_100902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000244/form4-09242025_100902.xml","form_type":"4"}},{"id":1035524,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-19T22:03:12.000Z","date":"2025-09-19","kind":"sale","planned":false,"acquired":false,"shares":3656,"price":1.79,"value":6544.24,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1859333,"source":{"system":"sec-edgar","filing":"0001231919-25-000221","document":"form4-09192025_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000221/form4-09192025_100903.xml","form_type":"4"}},{"id":1035523,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-19T22:03:12.000Z","date":"2025-09-18","kind":"sale","planned":false,"acquired":false,"shares":5307,"price":1.74,"value":9234.18,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1862989,"source":{"system":"sec-edgar","filing":"0001231919-25-000221","document":"form4-09192025_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000221/form4-09192025_100903.xml","form_type":"4"}},{"id":1035522,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-19T22:03:12.000Z","date":"2025-09-17","kind":"sale","planned":false,"acquired":false,"shares":2304,"price":1.83,"value":4216.32,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.80 to $1.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1868296,"source":{"system":"sec-edgar","filing":"0001231919-25-000221","document":"form4-09192025_100903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000123191925000221/form4-09192025_100903.xml","form_type":"4"}},{"id":1039294,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-16T23:45:49.000Z","date":"2025-09-16","kind":"sale","planned":false,"acquired":false,"shares":840,"price":1.88,"value":1579.2,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.86 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1870600,"source":{"system":"sec-edgar","filing":"0001736814-25-000007","document":"form4-09162025_110941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000173681425000007/form4-09162025_110941.xml","form_type":"4"}},{"id":1039293,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-16T23:45:49.000Z","date":"2025-09-15","kind":"sale","planned":false,"acquired":false,"shares":2570,"price":1.84,"value":4728.8,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.77 to $1.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1871440,"source":{"system":"sec-edgar","filing":"0001736814-25-000007","document":"form4-09162025_110941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000173681425000007/form4-09162025_110941.xml","form_type":"4"}},{"id":1039292,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-16T23:45:49.000Z","date":"2025-09-12","kind":"sale","planned":false,"acquired":false,"shares":700,"price":1.85,"value":1295.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.83 to $1.87 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1874010,"source":{"system":"sec-edgar","filing":"0001736814-25-000007","document":"form4-09162025_110941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000173681425000007/form4-09162025_110941.xml","form_type":"4"}},{"id":1042793,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-11T23:43:40.000Z","date":"2025-09-11","kind":"sale","planned":false,"acquired":false,"shares":3820,"price":1.9,"value":7258.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $1.94 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1874710,"source":{"system":"sec-edgar","filing":"0001415889-25-024317","document":"form4-09112025_110935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925024317/form4-09112025_110935.xml","form_type":"4"}},{"id":1042792,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-11T23:43:40.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":8176,"price":1.93,"value":15779.68,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $2.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1878530,"source":{"system":"sec-edgar","filing":"0001415889-25-024317","document":"form4-09112025_110935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925024317/form4-09112025_110935.xml","form_type":"4"}},{"id":1042791,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-11T23:43:40.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":9050,"price":1.97,"value":17828.5,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $2.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1886706,"source":{"system":"sec-edgar","filing":"0001415889-25-024317","document":"form4-09112025_110935.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925024317/form4-09112025_110935.xml","form_type":"4"}},{"id":1045794,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-08T22:55:36.000Z","date":"2025-09-08","kind":"sale","planned":false,"acquired":false,"shares":7090,"price":1.93,"value":13683.7,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1895756,"source":{"system":"sec-edgar","filing":"0001415889-25-023907","document":"form4-09082025_100931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023907/form4-09082025_100931.xml","form_type":"4"}},{"id":1045793,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-08T22:55:36.000Z","date":"2025-09-05","kind":"sale","planned":false,"acquired":false,"shares":1106,"price":1.86,"value":2057.16,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.82 to $1.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1902846,"source":{"system":"sec-edgar","filing":"0001415889-25-023907","document":"form4-09082025_100931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023907/form4-09082025_100931.xml","form_type":"4"}},{"id":1045792,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-08T22:55:36.000Z","date":"2025-09-04","kind":"sale","planned":false,"acquired":false,"shares":803,"price":1.82,"value":1461.46,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1903952,"source":{"system":"sec-edgar","filing":"0001415889-25-023907","document":"form4-09082025_100931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023907/form4-09082025_100931.xml","form_type":"4"}},{"id":1049541,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-03T23:57:06.000Z","date":"2025-09-03","kind":"sale","planned":false,"acquired":false,"shares":1270,"price":1.81,"value":2298.7,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1904755,"source":{"system":"sec-edgar","filing":"0001415889-25-023607","document":"form4-09032025_110901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023607/form4-09032025_110901.xml","form_type":"4"}},{"id":1049540,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-03T23:57:06.000Z","date":"2025-09-02","kind":"sale","planned":false,"acquired":false,"shares":2800,"price":1.78,"value":4984.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.67 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1906025,"source":{"system":"sec-edgar","filing":"0001415889-25-023607","document":"form4-09032025_110901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023607/form4-09032025_110901.xml","form_type":"4"}},{"id":1049539,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-03T23:57:06.000Z","date":"2025-08-29","kind":"sale","planned":false,"acquired":false,"shares":800,"price":1.74,"value":1392.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.80 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1908825,"source":{"system":"sec-edgar","filing":"0001415889-25-023607","document":"form4-09032025_110901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023607/form4-09032025_110901.xml","form_type":"4"}},{"id":1053551,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-29T00:39:13.000Z","date":"2025-08-28","kind":"sale","planned":false,"acquired":false,"shares":809,"price":1.81,"value":1464.29,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.82 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1909625,"source":{"system":"sec-edgar","filing":"0001415889-25-023258","document":"form4-08292025_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023258/form4-08292025_120807.xml","form_type":"4"}},{"id":1053550,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-29T00:39:13.000Z","date":"2025-08-27","kind":"sale","planned":false,"acquired":false,"shares":1300,"price":1.78,"value":2314.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.82 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1910434,"source":{"system":"sec-edgar","filing":"0001415889-25-023258","document":"form4-08292025_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023258/form4-08292025_120807.xml","form_type":"4"}},{"id":1053549,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-29T00:39:13.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":1.79,"value":3580.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.76 to $1.84 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1911734,"source":{"system":"sec-edgar","filing":"0001415889-25-023258","document":"form4-08292025_120807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925023258/form4-08292025_120807.xml","form_type":"4"}},{"id":1056798,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-25T23:46:54.000Z","date":"2025-08-25","kind":"sale","planned":false,"acquired":false,"shares":300,"price":1.77,"value":531.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.78 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1913734,"source":{"system":"sec-edgar","filing":"0001415889-25-022967","document":"form4-08252025_110849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022967/form4-08252025_110849.xml","form_type":"4"}},{"id":1056797,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-25T23:46:54.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":2376,"price":1.75,"value":4158.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.77 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1914034,"source":{"system":"sec-edgar","filing":"0001415889-25-022967","document":"form4-08252025_110849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022967/form4-08252025_110849.xml","form_type":"4"}},{"id":1056796,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-25T23:46:54.000Z","date":"2025-08-21","kind":"sale","planned":false,"acquired":false,"shares":3034,"price":1.79,"value":5430.86,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1916410,"source":{"system":"sec-edgar","filing":"0001415889-25-022967","document":"form4-08252025_110849.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022967/form4-08252025_110849.xml","form_type":"4"}},{"id":1060206,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T22:35:28.000Z","date":"2025-08-20","kind":"sale","planned":false,"acquired":false,"shares":3456,"price":1.74,"value":6013.44,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.72 to $1.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1919444,"source":{"system":"sec-edgar","filing":"0001415889-25-022532","document":"form4-08202025_100823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022532/form4-08202025_100823.xml","form_type":"4"}},{"id":1060205,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T22:35:28.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":3604,"price":1.77,"value":6379.08,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.75 to $1.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1922900,"source":{"system":"sec-edgar","filing":"0001415889-25-022532","document":"form4-08202025_100823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022532/form4-08202025_100823.xml","form_type":"4"}},{"id":1060204,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-20T22:35:28.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":47668,"price":2.03,"value":96766.04,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.85 to $2.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1926504,"source":{"system":"sec-edgar","filing":"0001415889-25-022532","document":"form4-08202025_100823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022532/form4-08202025_100823.xml","form_type":"4"}},{"id":1065270,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-15T23:11:59.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":2900,"price":2,"value":5800.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1974172,"source":{"system":"sec-edgar","filing":"0001415889-25-022119","document":"form4-08152025_110853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022119/form4-08152025_110853.xml","form_type":"4"}},{"id":1065269,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-15T23:11:59.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":2,"value":4000.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares vat each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Decheng Capital Management III (Cayman), LLC (\"GP III\") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1977072,"source":{"system":"sec-edgar","filing":"0001415889-25-022119","document":"form4-08152025_110853.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925022119/form4-08152025_110853.xml","form_type":"4"}},{"id":1070145,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-08-04","kind":"sale","planned":false,"acquired":false,"shares":2196,"price":2.18,"value":4787.28,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":891734,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070144,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-18","kind":"sale","planned":false,"acquired":false,"shares":900,"price":2.2,"value":1980.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":893930,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070143,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-17","kind":"sale","planned":false,"acquired":false,"shares":20572,"price":2.19,"value":45052.68,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":894830,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070142,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-16","kind":"sale","planned":false,"acquired":false,"shares":5396,"price":2.24,"value":12087.04,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":915402,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070141,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-15","kind":"sale","planned":false,"acquired":false,"shares":2152,"price":2.28,"value":4906.56,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":920798,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070140,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-14","kind":"sale","planned":false,"acquired":false,"shares":801,"price":2.29,"value":1834.29,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":922950,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070139,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-11","kind":"sale","planned":false,"acquired":false,"shares":246,"price":2.29,"value":563.34,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":923751,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070138,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-10","kind":"sale","planned":false,"acquired":false,"shares":768,"price":2.28,"value":1751.04,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":923997,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070137,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":252,"price":2.27,"value":572.04,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":924765,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070136,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-08","kind":"sale","planned":false,"acquired":false,"shares":9059,"price":2.29,"value":20745.11,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":925017,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070135,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-02","kind":"sale","planned":false,"acquired":false,"shares":324,"price":2.42,"value":784.08,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":934076,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070134,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-07-01","kind":"sale","planned":false,"acquired":false,"shares":600,"price":2.43,"value":1458.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":934400,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070133,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-23","kind":"sale","planned":false,"acquired":false,"shares":1700,"price":3.09,"value":5253.0,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.06 to $3.19 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. (\"Fund II\"). Decheng Capital Management II (Cayman), LLC (\"GP II\") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1617409,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070132,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":225217,"price":3.16,"value":711685.72,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.05 to $3.27 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. (\"Fund II\"). Decheng Capital Management II (Cayman), LLC (\"GP II\") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1619109,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070131,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-20","kind":"sale","planned":false,"acquired":false,"shares":60000,"price":3.11,"value":186600.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":935000,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070130,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-18","kind":"sale","planned":false,"acquired":false,"shares":59253,"price":3.17,"value":187832.01,"ownership":{"direct":false,"nature":"By Decheng Capital China Life Sciences USD Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.10 to $3.34 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. (\"Fund II\"). Decheng Capital Management II (Cayman), LLC (\"GP II\") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":1844326,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1070129,"issuer":{"id":7539,"kind":"organization","name":"BeyondSpring Inc."},"owners":[{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":1,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":2,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74131,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund II, L.P.","position":3,"cik":"0001650291","reported_name":"Decheng Capital China Life Sciences USD Fund II, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":6,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Ordinary Shares","published_at":"2025-08-11T21:07:18.000Z","date":"2025-06-17","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":3.23,"value":16150.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":995000,"source":{"system":"sec-edgar","filing":"0001415889-25-021441","document":"form4-08112025_090812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588925021441/form4-08112025_090812.xml","form_type":"4"}},{"id":1259804,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2025-02-19T22:44:41.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":2825337,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":333412},"source":{"system":"sec-edgar","filing":"0000950170-25-023409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000095017025023409/ownership.xml","form_type":"4"}},{"id":1259803,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2025-02-19T22:44:41.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":19777363,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Life Sciences Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. (\"Fund IV\"). Decheng Capital Management IV (Cayman), LLC (\"GP IV\") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2333887},"source":{"system":"sec-edgar","filing":"0000950170-25-023409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000095017025023409/ownership.xml","form_type":"4"}},{"id":1259802,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T22:44:41.000Z","date":"2025-02-14","kind":"purchase","planned":false,"acquired":true,"shares":625000,"price":16,"value":10000000.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":958412,"source":{"system":"sec-edgar","filing":"0000950170-25-023409","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000095017025023409/ownership.xml","form_type":"4"}},{"id":1259801,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T22:44:41.000Z","date":"2025-02-14","kind":"purchase","planned":false,"acquired":true,"shares":625000,"price":16,"value":10000000.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Life Sciences Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. (\"Fund IV\"). Decheng Capital Management IV (Cayman), LLC (\"GP IV\") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":2958887,"source":{"system":"sec-edgar","filing":"0000950170-25-023409","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000095017025023409/ownership.xml","form_type":"4"}},{"id":1259800,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T22:44:41.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":333412,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":333412,"source":{"system":"sec-edgar","filing":"0000950170-25-023409","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000095017025023409/ownership.xml","form_type":"4"}},{"id":1259799,"issuer":{"id":6598,"kind":"organization","name":"Aardvark Therapeutics, Inc.","symbol":"AARD"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T22:44:41.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":2333887,"ownership":{"direct":false,"nature":"By Decheng Capital Global Life Sciences Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the \"Issuer\") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock (\"Common Stock\") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series C Convertible Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. (\"Fund IV\"). Decheng Capital Management IV (Cayman), LLC (\"GP IV\") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":2333887,"source":{"system":"sec-edgar","filing":"0000950170-25-023409","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000095017025023409/ownership.xml","form_type":"4"}},{"id":1508933,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"1/12th of the shares subject to the option become vested and exercisable on February 2, 2024 and 1/12 of the shares subject to the option shall vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":19,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508932,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.43,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508931,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.89,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508930,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7650,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.45,"expiration_date":"2031-01-03","underlying":"Common Stock","underlying_shares":7650},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508929,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7650,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.6233,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":7650},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508928,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7650,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, as of immediately prior to the Effective Time, each option to purchase shares of Company Common Stock (a Company Option) that was then outstanding but not then vested or exercisable became immediately vested and exercisable in full. At the Effective Time, each Company Option that was then outstanding was automatically cancelled and, if such Company Option had a per share exercise price less than the Merger Consideration, the holder thereof became entitled to receive a cash payment, without interest thereon and subject to any applicable tax withholding, equal to the product obtained by multiplying (i) the total number of shares of Company Common Stock underlying such Company Option by (ii) the excess of the Merger Consideration over the exercise price per share such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"(Continued from Footnote 7)  Any Company Option that had an exercise price per share that was equal to or exceeded the Merger Consideration was cancelled without any cash payment or other consideration being made in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option to purchase shares of Company Common Stock (the Company Option) is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.7008,"expiration_date":"2029-01-17","underlying":"Common Stock","underlying_shares":7650},"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508927,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-18","kind":"other","planned":false,"acquired":false,"shares":1735544,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated April 10, 2024, among Alpine Immune Sciences, Inc., a Delaware corporation (the Company), Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (Parent), and Adams Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (Merger Sub). Pursuant to the Merger Agreement, Merger Sub completed a tender offer for shares of the Companys Common Stock, par value $0.001 per share (Company Common Stock), effective May 18, 2024 (the Offer Closing), and thereafter merged with and into the Company (the Merger, and together with the Offer Closing, the Transactions), effective May 20, 2024 (the Effective Time), with the Company surviving the Merger as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) In connection with the consummation of the Transactions, each share of the Company Common Stock was either (x) purchased at the Offer Closing for $65.00 in cash per share (the Offer Price), without interest thereon and subject to any applicable tax withholding or (y) automatically converted in the Merger at the Effective Time into the right to receive the Offer Price in cash, without interest thereon (the Merger Consideration), subject to any applicable tax withholding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are owned directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Decheng Capital Global Healthcare GP, LLC, the general partner of Healthcare.  Dr. Cui disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1508926,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74129,"kind":"organization","name":"Decheng Capital China Life Sciences USD Fund III, L.P.","position":2,"cik":"0001736814","reported_name":"Decheng Capital China Life Sciences USD Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74130,"kind":"organization","name":"Decheng Capital Management III (Cayman), LLC","position":3,"cik":"0001747821","reported_name":"Decheng Capital Management III (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":4,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":5,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T00:08:26.000Z","date":"2024-05-18","kind":"other","planned":false,"acquired":false,"shares":6582380,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the Merger Agreement), dated April 10, 2024, among Alpine Immune Sciences, Inc., a Delaware corporation (the Company), Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (Parent), and Adams Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (Merger Sub). Pursuant to the Merger Agreement, Merger Sub completed a tender offer for shares of the Companys Common Stock, par value $0.001 per share (Company Common Stock), effective May 18, 2024 (the Offer Closing), and thereafter merged with and into the Company (the Merger, and together with the Offer Closing, the Transactions), effective May 20, 2024 (the Effective Time), with the Company surviving the Merger as a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) In connection with the consummation of the Transactions, each share of the Company Common Stock was either (x) purchased at the Offer Closing for $65.00 in cash per share (the Offer Price), without interest thereon and subject to any applicable tax withholding or (y) automatically converted in the Merger at the Effective Time into the right to receive the Offer Price in cash, without interest thereon (the Merger Consideration), subject to any applicable tax withholding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly by Decheng Capital China Life Sciences USD Fund III, L.P. (\"Fund III\"). Xiangmin Cui is the manager of Decheng Capital Management III (Cayman), LLC, the general partner of Fund III. Dr. Cui disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001626199-24-000095","document":"wk-form4_1716250094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000162619924000095/wk-form4_1716250094.xml","form_type":"4"}},{"id":1544513,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-09T23:08:23.000Z","date":"2024-01-29","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":19,"value":7600000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. (\"Fund IV\"). Decheng Capital Management IV (Cayman), LLC (\"GP IV\") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":4958810,"source":{"system":"sec-edgar","filing":"0001415889-24-010609","document":"form4a-04092024_110416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588924010609/form4a-04092024_110416.xml","form_type":"4/A","original_submission_date":"2024-01-31"}},{"id":1665118,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2024-01-31T21:17:10.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":false,"shares":4402320,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. (\"Fund IV\"). Decheng Capital Management IV (Cayman), LLC (\"GP IV\") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":461701},"source":{"system":"sec-edgar","filing":"0001415889-24-002062","document":"form4-01312024_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588924002062/form4-01312024_090105.xml","form_type":"4"}},{"id":1665117,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Preferred Stock","published_at":"2024-01-31T21:17:10.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":false,"shares":21547685,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. (\"Fund IV\"). Decheng Capital Management IV (Cayman), LLC (\"GP IV\") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2259851},"source":{"system":"sec-edgar","filing":"0001415889-24-002062","document":"form4-01312024_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588924002062/form4-01312024_090105.xml","form_type":"4"}},{"id":1665116,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2024-01-31T21:17:10.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":false,"shares":8644891,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. (\"Fund IV\"). Decheng Capital Management IV (Cayman), LLC (\"GP IV\") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":906648},"source":{"system":"sec-edgar","filing":"0001415889-24-002062","document":"form4-01312024_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588924002062/form4-01312024_090105.xml","form_type":"4"}},{"id":1665115,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T21:17:10.000Z","date":"2024-01-29","kind":"purchase","planned":false,"acquired":true,"shares":400000,"price":19,"value":7600000.0,"ownership":{"direct":false,"nature":"By Decheng Capital Global Healthcare Fund (Master), LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Xiangmin Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":400000,"source":{"system":"sec-edgar","filing":"0001415889-24-002062","document":"form4-01312024_090105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588924002062/form4-01312024_090105.xml","form_type":"4"}},{"id":1665114,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":83056,"kind":"organization","name":"Decheng Capital Global Life Sciences Fund IV, L.P.","position":1,"cik":"0001834150","reported_name":"Decheng Capital Global Life Sciences Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":83057,"kind":"organization","name":"Decheng Capital Management IV (Cayman), LLC","position":2,"cik":"0001843384","reported_name":"Decheng Capital Management IV (Cayman), LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":3,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":4,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":44249,"kind":"person","name":"Cui Xiangmin","position":5,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-31T21:17:10.000Z","date":"2024-01-29","kind":"exercise","planned":false,"acquired":true,"shares":3628198,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Decheng Capital Global Life Sciences Fund IV, L.P. (\"Fund IV\"). Decheng Capital Management IV (Cayman), LLC (\"GP IV\") is the general partner of Fund IV. Xiangmin Cui is the manager of GP IV. Each of Fund IV, GP IV and Dr. Cui may be deemed to beneficially own the securities held by Fund IV. Each of GP IV and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein."}],"balance_after":4558812,"source":{"system":"sec-edgar","filing":"0001415889-24-002062","document":"form4-01312024_090105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487815/000141588924002062/form4-01312024_090105.xml","form_type":"4"}},{"id":1741882,"issuer":{"id":90802,"kind":"organization","name":"ALPINE IMMUNE SCIENCES, INC.","symbol":"ALPN"},"owners":[{"id":74133,"kind":"organization","name":"Decheng Capital Global Healthcare Fund (Master), LP","position":1,"cik":"0001949026","reported_name":"Decheng Capital Global Healthcare Fund (Master), LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74134,"kind":"organization","name":"Decheng Capital Global Healthcare GP, LLC","position":2,"cik":"0001949027","reported_name":"Decheng Capital Global Healthcare GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-14T17:36:42.000Z","date":"2023-11-09","kind":"purchase","planned":false,"acquired":true,"shares":375000,"price":12.5,"value":4687500.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reportable securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP (\"Healthcare\"). Decheng Capital Global Healthcare GP, LLC (\"Healthcare GP\") is the general partner of Healthcare. Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Healthcare GP. Each of Healthcare, Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Healthcare GP disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. Dr. Cui is a director of the Issuer and files separate Section 16 reports."}],"balance_after":1735544,"source":{"system":"sec-edgar","filing":"0001209191-23-055210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1626199/000120919123055210/doc4.xml","form_type":"4"}}]}